Smith RD, Coast J, Millar MR. 1996. Over-the-counter antimicrobials: the hidden costs of resistance. Journal of Antimicrobial Chemotherapy37:1031–1032.
Smith RD, Coast J, Millar MR, Wilton P, Karcher A-M. 2001. Interventions Against Anti-Microbial Resistance: a Review of the Literature and Exploration of Modelling Cost- Effectiveness. Report to: Global Forum for Health Research.Geneva: World Health Organization.
Standing Medical Advisory Committee Sub-Group on Antimicrobial Resistance. 1998. The Path of Least Resistance. [Online]. Available: http://www.doh.gov.uk/smac1.htm.
Tietenberg T. 1990. Economic instruments for environmental regulation. Oxford Review of Economic Policy6:17–33.
Tomasz A. 1994. Multiple-antibiotic resistant pathogenic bacteria. A report on the Rockefeller University workshop. New England Journal of Medicine330:1247–1251.
Turner R, Pearce D, Bateman I. 1994. Environmental Economics. An Elementary Introduc tion.London: Harvester Wheatsheaf.
Weitzman M. 1974. Prices versus quantities. Review of Economic Studies41:477–491.
WHO (World Health Organization). 2001. Global Strategy for the Containment of Antimi crobial Resistance.WHO/CDS/CSR/DRS/2001.2. Geneva: WHO.
Wilton P, Smith RD, Coast J, Millar M. 2002. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness. Journal of Health Services Research and Policy7:111–117.
Wilton P, Smith RD, Coast J, Millar M, Karcher A. 2001. Directly observed therapy for multi-drug resistant tuberculosis: an economic evaluation in the United States of America and South Africa. The International Journal of Tuberculosis and Lung Disease5:1137– 1142.
Winebrake J, Farrell A, Bernstein M. 1995. The Clean Air Act’s sulfur dioxide emissions market: estimating the costs of regulatory and legislative intervention. Resource and Energy Economics17:239–260.
World Bank. 2001. World Development Report 2000/01. New York: Oxford University Press.